Mathilde CHAMPEAU will defend her PhD thesis entitled "Dissolving microneedles for an optimal transdermal delivery of an active principle used in photodynamic therapy: Development and proof of [...]

Alexandre QUILBE will defend his thesis entitled "IN VITRO AND IN VIVO EVALUATION OF TWO NEW THERAPEUTIC STRATEGIES TARGETED IN PANCREATIC ADENOCARCINOMA: Immunotherapy targeting Immune Checkpoint [...]

  Dr. Henri AZAIS, defended on September 22 at the Faculty of Medicine of Lille, the accreditation to direct research (HDR). Much of his presentation focused on his research project at OncoThAI [...]

The meeting to set up the pilot, monocentric, descriptive, feasibility, safety and tolerance study of the BUBOLight® device "took place on September 14 at the Jeanne de Flandre Maternity Unit of the [...]

On September 3, 2020, OncoThAI had the honor to welcome, an INSERM delegation chaired by Prof. Gilles BLOCH, Chairman and CEO of INSERM.

 French standard NF G20-030: Luminous textiles - Determination of the irradiance and luminance of luminous fabrics has just been published. OncoThAI, in particular, Elise THECUA, participated in [...]

  Hemerion Therapeutics (, is a start-up spin-off from the OncoThAI laboratory (Pr. S. Mordon). Hemerion becomes the winner of the ILab 2020 French competition. Hemerion [...]

The article entitled "A facile fabrication of dissolving microneedles containing 5-aminolevulinic acid" By Mathilde CHAMPEAU and al is now online. This project is performed thanks to a collaboration [...]